Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection

NCT02086916 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.

NCT NCT02086916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02086916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection
Lead sponsor
Barts & The London NHS Trust
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
December 31, 2015
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection